Starling Oncology (STLN)
Community cancer-care platform combining clinics, specialty pharmacy, and value-based payer contracts.
$5.95
Pre-market−0.14 (−2.30%)
At close$6.09(+2.53%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Insiders2 holders · as of Aug 24, 2026 | 11.07% | 11.07M shares | |
| Otherremainder | 88.93% | 88.91M shares |
99.98M company shares as of Aug 21, 2026 · holders as of their latest filing
The share count has not been confirmed by a second filing; stakes use it as it stands.
Institutions13F
No 13F holders on record.
Ownership statements13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 21, 2026 | Brad Hivelydirector | Sale | 298,853 | $6.51 | 411,976 |
| Aug 13, 2026 | Jorey Chernett10 percent owner | Sale | 100 | $9.00 | 0 |
| Aug 14, 2026 | Jorey Chernett10 percent owner | Purchase | 12,000 | $6.54 | 10,660,858 |
CongressHouse and Senate disclosures
Not reported.